Global Medical REIT Inc. (GMRE)

NYSE: GMRE · IEX Real-Time Price · USD
11.47
+0.24 (2.14%)
At close: Jul 1, 2022 4:00 PM
11.50
+0.03 (0.26%)
After-hours: Jul 1, 2022 7:52 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015
Revenue
115.9493.7370.7353.1930.348.212.06
Revenue Growth (YoY)
23.69%32.53%32.96%75.30%269.55%298.21%-
Gross Profit
115.9493.7370.7353.1930.348.212.06
Selling, General & Admin
16.4511.946.545.545.494.220.43
Other Operating Expenses
62.5165.6137.1325.7917.516.211.73
Operating Expenses
78.9777.5543.6731.332310.432.15
Operating Income
36.9716.1827.0621.867.35-2.21-0.09
Interest Expense / Income
19.718.6817.4714.987.444.141.52
Other Expense / Income
-0.35-0.570.35-6.6-0.0500
Pretax Income
17.62-1.939.2313.49-0.04-6.35-1.61
Net Income
17.62-1.939.2313.49-0.04-6.35-1.61
Preferred Dividends
5.825.825.825.821.7100
Net Income Common
11.8-7.753.417.67-1.75-6.35-1.61
Net Income Growth
---55.50%----
Shares Outstanding (Basic)
614634222090
Shares Outstanding (Diluted)
614634222090
Shares Change
31.10%36.59%54.13%12.00%110.89%3620.80%-
EPS (Basic)
0.19-0.170.100.35-0.09-0.68-6.44
EPS (Diluted)
0.19-0.170.100.35-0.09-0.68-6.44
EPS Growth
---71.43%----
Free Cash Flow Per Share
-2.07-3.98-6.55-5.77-12.23-16.41-129.65
Dividend Per Share
0.8200.8000.8000.8000.8000.400-
Dividend Growth
2.50%---100.00%--
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
31.89%17.26%38.26%41.10%24.22%-26.96%-4.37%
Profit Margin
10.18%-8.27%4.82%14.42%-5.77%-77.37%-78.03%
Free Cash Flow Margin
-108.37%-196.40%-313.54%-238.26%-790.85%-1859.24%-1571.87%
EBITDA
71.1443.545.8842.1115.330.120.57
EBITDA Margin
61.36%46.41%64.87%79.16%50.51%1.47%27.64%
Depreciation & Amortization
33.8326.7519.1813.647.932.340.66
EBIT
37.3216.7626.7128.477.4-2.21-0.09
EBIT Margin
32.19%17.88%37.76%53.51%24.38%-26.96%-4.37%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).